Dabigatran may be a cost-effective alternative to warfarin for stroke prevention in atrial fibrillation

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2011年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Kapur, A. K.
    Chatzitheofilou, I
    Schang, L. K.
    VALUE IN HEALTH, 2012, 15 (04) : A122 - A122
  • [42] Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
    Lee, Soyon
    Mullin, Rachel
    Blazawski, Jon
    Coleman, Craig I.
    PLOS ONE, 2012, 7 (10):
  • [43] Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
    Lee, Soyon
    Anglade, Moise W.
    Dan Pham
    Pisacane, Robyn
    Kluger, Jeffrey
    Coleman, Craig I.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06): : 845 - 851
  • [44] Dabigatran is a new option for stroke prevention in atrial fibrillation
    Lyon, Sue
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (10) : 559 - 559
  • [45] Hemopericardium under dabigatran for stroke prevention in atrial fibrillation
    Stoellberger, Claudia
    Heger, Maria
    Finsterer, Josef
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (02) : 185 - 188
  • [46] Dabigatran for Stroke Prevention in All Patients with Atrial Fibrillation?
    Hunchuck, Jonathan E.
    Lake, Jennifer D.
    PHARMACOTHERAPY, 2011, 31 (08): : 725 - 728
  • [47] GLOBAL COST EFFECTIVE ANALYSIS OF APIXABAN VERSUS WARFARIN FOR THE PREVENTION OF STROKE AS A RESULT OF ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW
    Petrenchik, L.
    Hussain, N.
    Charles, P.
    Peprah, H.
    Loh, F. E.
    VALUE IN HEALTH, 2018, 21 : S61 - S61
  • [48] COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN FOR THE PREVENTION OF STROKE IN IRANIAN ATRIAL FIBRILLATION PATIENTS
    Keshavarz, K.
    Meshkini, Hashemi A.
    Nikfar, S.
    Ashkuh, M. S.
    Sanati, E.
    VALUE IN HEALTH, 2016, 19 (07) : A654 - A654
  • [49] Warfarin or Dabigatran in patients with atrial fibrillation
    Meinertz, T.
    Nitschmann, S.
    INTERNIST, 2011, 52 (04): : 462 - +
  • [50] Warfarin or dabigatran for treatment of atrial fibrillation
    Poller, L.
    Jespersen, J.
    Ibrahim, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (07) : 1193 - 1195
12345